Stay updated on Subcutaneous Nivolumab + rHuPH20 Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous Nivolumab + rHuPH20 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous Nivolumab + rHuPH20 Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.4, replacing v3.5.3, indicating a minor template/metadata update to the study details page. This adjustment does not alter the study information displayed.
    Difference
    0.0%
    Check dated 2026-05-18T13:57:23.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    This update refreshes the ClinicalTrials.gov page’s revision/version label (v3.5.3), without changing the study’s substantive details.
    Difference
    0.0%
    Check dated 2026-04-27T07:34:05.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-20T02:46:41.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Padua, Italy, 35128 was replaced with Padova, Italy, 35128 in the locations list.
    Difference
    0.0%
    Check dated 2026-04-05T16:44:44.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.5.0 has been added and Revision: v3.4.3 has been removed. This appears to be a UI/version update with no changes to study data or content.
    Difference
    0.0%
    Check dated 2026-03-22T04:40:44.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    Revision log updated: added v3.4.3 and removed v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-15T00:29:55.000Z thumbnail image

Stay in the know with updates to Subcutaneous Nivolumab + rHuPH20 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous Nivolumab + rHuPH20 Clinical Trial page.